Voyager Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
Last updated:
Abstract:
The present disclosure relates to methods, formulations and devices for the delivery and therapeutic administration of polynucleotides encoding AADC. The present disclosure relates to methods, formulations and devices for the delivery and therapeutic administration of AAV vectors which include polynucleotides encoding AADC. The present disclosure relates to methods, formulations and devices for the delivery and therapeutic administration of polynucleotides encoding AADC in the treatment of neurological diseases, disorders and conditions, including Parkinson's Disease.
Status:
Application
Type:
Utility
Filling date:
15 May 2019
Issue date:
1 Jul 2021